Skip to main
  1. Stocks
  2. Medtronic
  3. Forecast
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 30%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is positioned for sustained fundamental outperformance because multiple growth engines are now compounding at once, led by Cardiac Ablation Solutions, which surpassed $2B in trailing 12-month revenue as of September 2026 and is expected to keep driving share gains in electrophysiology. The broader portfolio adds optionality through renal denervation, Altaviva, Hugo robotics, AVIM, CathWorks, and recent acquisitions, supporting a modeled >5% annual top-line growth rate through 2030 versus consensus closer to 4%-5%. Its valuation remains reasonable near a 5-year average P/E, while mix shift toward higher-margin therapies and potential reimbursement expansion should support earnings upside and margin expansion.

Bears say

Medtronic is facing a mixed but ultimately fragile setup, with FY27 guidance only modestly improved and still dependent on mid-single-digit organic growth, FX headwinds, and EPS of just $5.94-$6.00 despite a revenue outlook of roughly $38.9B-$39.2B. The bearish case is driven by slower product growth, competitive encroachment in key segments, potential regulatory delays, and macro weakness, while tariff relief is not yet embedded in guidance. Recent investments in Pi-Cardia and Cornerstone Robotics may broaden the portfolio, but they also underscore strategic pressure around structural heart and robotics, raising questions about the durability of Hugo and execution quality.

Medtronic (MDT) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 30% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Medtronic (MDT) Analyst Forecast & Price Prediction

Get the latest Medtronic (MDT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Medtronic (MDT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 20 analysts, Medtronic (MDT) has a Buy consensus rating as of Nov 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Medtronic (MDT) Analyst Forecast & Price Prediction

Get the latest Medtronic (MDT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Medtronic (MDT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MDT stock data and trends